Filtered By:
Source: Expert Review of Neurotherapeutics
Drug: Clonazepam
This page shows you your search results in order of date.
Order by Relevance | Date
Total 329 results found since Jan 2013.
Diagnostic and therapeutic approach to drug-resistant Juvenile Myoclonic Epilepsy
Expert Rev Neurother. 2021 May 17. doi: 10.1080/14737175.2021.1931126. Online ahead of print.ABSTRACTINTRODUCTION: Juvenile myoclonic epilepsy (JME), also known as Janz syndrome, is a common form of generalized epilepsy of presumed genetic origin representing up to 10% of all epilepsy cases. Despite adequate anti-seizure medication (ASM) treatment, seizures persist in one-third of JME patients.AREAS COVERED: A literature search was conducted using Pubmed search on the topics of drug-resistant JME.EXPERT OPINION: About 30% of JME patients are drug-resistant. Valproate (VPA) is considered the first-choice drug. In women of c...
Source: Expert Review of Neurotherapeutics - May 17, 2021 Category: Neurology Authors: Michele Ascoli Giovanni Mastroianni Sara Gasparini Pasquale Striano Vittoria Cianci Sabrina Neri Valentina Bova Anna Mamm ì Antonio Gambardella Angelo Labate Umberto Aguglia Edoardo Ferlazzo Source Type: research
Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy
Expert Rev Neurother. 2021 May 25:1-9. doi: 10.1080/14737175.2021.1931126. Online ahead of print.ABSTRACTINTRODUCTION: Juvenile myoclonic epilepsy (JME), also known as Janz syndrome, is a common form of generalized epilepsy of presumed genetic origin representing up to 10% of all epilepsy cases. Despite adequate anti-seizure medication (ASM) treatment, seizures persist in one-third of JME patients.AREAS COVERED: A literature search was conducted using Pubmed search on the topics of drug-resistant JME.EXPERT OPINION: About 30% of JME patients are drug-resistant. Valproate (VPA) is considered the first-choice drug. In women ...
Source: Expert Review of Neurotherapeutics - May 17, 2021 Category: Neurology Authors: Michele Ascoli Giovanni Mastroianni Sara Gasparini Pasquale Striano Vittoria Cianci Sabrina Neri Valentina Bova Anna Mamm ì Antonio Gambardella Angelo Labate Umberto Aguglia Edoardo Ferlazzo Source Type: research
Diagnostic and therapeutic approach to drug-resistant Juvenile Myoclonic Epilepsy
Expert Rev Neurother. 2021 May 17. doi: 10.1080/14737175.2021.1931126. Online ahead of print.ABSTRACTINTRODUCTION: Juvenile myoclonic epilepsy (JME), also known as Janz syndrome, is a common form of generalized epilepsy of presumed genetic origin representing up to 10% of all epilepsy cases. Despite adequate anti-seizure medication (ASM) treatment, seizures persist in one-third of JME patients.AREAS COVERED: A literature search was conducted using Pubmed search on the topics of drug-resistant JME.EXPERT OPINION: About 30% of JME patients are drug-resistant. Valproate (VPA) is considered the first-choice drug. In women of c...
Source: Expert Review of Neurotherapeutics - May 17, 2021 Category: Neurology Authors: Michele Ascoli Giovanni Mastroianni Sara Gasparini Pasquale Striano Vittoria Cianci Sabrina Neri Valentina Bova Anna Mamm ì Antonio Gambardella Angelo Labate Umberto Aguglia Edoardo Ferlazzo Source Type: research
